Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001171753 | SCV001334593 | likely benign | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001171753 | SCV003265351 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001171753 | SCV005259954 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003928772 | SCV004743422 | likely benign | VPS13D-related disorder | 2022-04-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |